Functional importance of C242T polymorphism in NAD(P)H oxidase p22phox subunit on vascular superoxide production in atherosclerosis

Functional importance of C242T polymorphism in NAD(P)H oxidase p22phox subunit on vascular superoxide production in atherosclerosis

Bibliographische Detailangaben
Hauptverfasser:	Guzik, T, West, N, Black, E, McDonald, D, Ratnatunga, C, Pillai, R, Channon, K
Format:	Journal article
Veröffentlicht:	2000

Ähnliche Einträge

Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis.
von: Guzik, T, et al.
Veröffentlicht: (2000)

Functional impact of genetic polymorphisms in NAD(P)H oxidase p22phox subunit on vascular superoxide production in atherosclerosis
von: Guzik, T, et al.
Veröffentlicht: (2000)

Relationships of promoter and coding sequence genetic polymorphisms of p22phox subunit to the vascular NAD(P)H oxidase activity
von: Guzik, T, et al.
Veröffentlicht: (2004)

Superoxide generation by NAD(P)H oxidase in human sphenous vein: Interaction with nitric oxide
von: Guzik, T, et al.
Veröffentlicht: (2000)

Superoxide production by NAD(P)H oxidase in human blood vessels: Functional interaction with nitric oxide
von: Guzik, T, et al.
Veröffentlicht: (2000)

Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.
von: Guzik, T, et al.
Veröffentlicht: (2000)

UltraRapid communications : vascular superoxide production by NAD(P)H OxidaseAssociation with endothelial dysfunction and clinical risk factors
von: Guzik, T, et al.
Veröffentlicht: (2000)

Systemic upregulation of vascular NAD(P)H oxidase in human atherosclerosis: Association with clinical risk factors.
von: Guzik, T, et al.
Veröffentlicht: (2000)

Association of superoxide production by NAD(P)H oxidase with systaemic endothelial dysfunction in human blood vessels: relationship to clinical risk factors
von: Guzik, T, et al.
Veröffentlicht: (2000)

Vascular superoxide generation by NAD(P)H oxidase is increased in humans with type II diabetes mellitus
von: Guzik, T, et al.
Veröffentlicht: (2001)

Enhanced superoxide anion production in experimental venous bypass grafts is mediated by NAD(P)H oxidase
von: West, N, et al.
Veröffentlicht: (2000)

Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase.
von: West, N, et al.
Veröffentlicht: (2001)

Relationship of NAD(P)H oxidase activity in human blood vessels to endothelial dysfunction and clinical risk factors
von: Guzik, T, et al.
Veröffentlicht: (2000)

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.
von: Guzik, T, et al.
Veröffentlicht: (2002)

Superoxide generation by NAD(P)H oxidases in human bypass graft vessels.
von: Guzik, T, et al.
Veröffentlicht: (2002)

The p22phox Polymorphism C242T Is Not Associated with Peripheral Malondialdehyde and Superoxide Dismutase Levels in Healthy Korean Adults
von: Su-Youn CHO, et al.
Veröffentlicht: (2019-05-01)

Superoxide generation during cardiopulmonary bypass in conventional coronary artery bypass graft surgery: is there a role for myocardial NAD(P)H oxidase?
von: Kim, Y, et al.
Veröffentlicht: (2004)

Association between NADPH oxidase p22(phox) C242T polymorphism and ischemic cerebrovascular disease: a meta-analysis.
von: Bing-Hu Li, et al.
Veröffentlicht: (2013-01-01)

Superoxide production by NAD(P)H oxidases in human bypass graft vessels - Role in the regulation of vascular tone
von: Guzik, T, et al.
Veröffentlicht: (2002)

A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation (AF)
von: Kim, Y, et al.
Veröffentlicht: (2003)

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation
von: Kim, Y, et al.
Veröffentlicht: (2005)

A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.
von: Kim, Y, et al.
Veröffentlicht: (2005)

The Effect of 8-Week Aerobic Exercise on the Expression of Regulatory Subunits of NADPH Oxidase 2 (p47phox and p67phox) in the Cardiac Tissue of Diabetic Rats
von: Hamid Taghi Beigi, et al.
Veröffentlicht: (2019-03-01)

HGF/c-Met regulates p22phox subunit of the NADPH oxidase complex in primary mouse hepatocytes by transcriptional and post-translational mechanisms
von: Arturo Simoni-Nieves, et al.
Veröffentlicht: (2021-11-01)

Ameliorating of Transcription Level of gp91Phox and P22Phox Subunits of NADPH Oxdisae Complex in Hypertrophied Heart of Rats by Resveratrol
von: Fatemeh Mirabdollahi Shamsi, et al.
Veröffentlicht: (2019-12-01)

Atrial NAD(P)H oxidase activity predicts the development of atrial fibrillation after coronary artery bypass graft surgery
von: Kim, Y, et al.
Veröffentlicht: (2006)

Molecular evolution of <it>Phox</it>-related regulatory subunits for NADPH oxidase enzymes
von: Lambeth J David, et al.
Veröffentlicht: (2007-09-01)

Atrial NAD(P)H oxidase activity predicts the development of atrial fibrillation after on-pump coronary artery bypass graft surgery
von: Kim, Y, et al.
Veröffentlicht: (2005)

Regulation of Derlin-1-mediated degradation of NADPH oxidase partner p22phox by thiol modification
von: Kei Miyano, et al.
Veröffentlicht: (2022-10-01)

Relationship of the p22phox (CYBA) gene polymorphism C242T with risk of coronary artery disease: a meta-analysis.
von: Zhijun Wu, et al.
Veröffentlicht: (2013-01-01)

Correction: Relationship of the p22phox () Gene Polymorphism C242T with Risk of Coronary Artery Disease: A Meta-Analysis.
von: Zhijun Wu, et al.
Veröffentlicht: (2013-01-01)

A myocardial nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation
von: Kim, Y, et al.
Veröffentlicht: (2005)

Letter regarding article by Becker et al, "Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase".
von: Antoniades, C, et al.
Veröffentlicht: (2005)

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins
von: Guzik, T, et al.
Veröffentlicht: (2004)

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.
von: Guzik, T, et al.
Veröffentlicht: (2004)

New NADPH Oxidase 2 Inhibitors Display Potent Activity against Oxidative Stress by Targeting p22<sup>phox</sup>-p47<sup>phox</sup> Interactions
von: Adriana V. Treuer, et al.
Veröffentlicht: (2023-07-01)

P.049 THE P22PHOX -930A/G POLYMORPHISM OF NADPH OXIDASE: AN INDEPENDENT GENETIC DETERMINANT OF WAVE REFLECTIONS
von: P. Xaplanteris, et al.
Veröffentlicht: (2007-08-01)

Correction: Relationship of the p22phox (CYBA) Gene Polymorphism C242T with Risk of Coronary Artery Disease: A Meta-Analysis
Veröffentlicht: (2013-01-01)

Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis.
von: Guzik, T, et al.
Veröffentlicht: (2001)

Increased NAD(P)H oxidase activity in coronary arteries from patients with coronary artery disease
von: Guzik, T, et al.
Veröffentlicht: (2001)